C. Chiriboga, S. Fleishman, S. Champion, L. Gaye-robinson, and E. Abrams, Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART), The Journal of Pediatrics, vol.146, issue.3, pp.402-407, 2005.
DOI : 10.1016/j.jpeds.2004.10.021

D. Gibb, T. Duong, P. Tookey, M. Sharland, G. Tudor-williams et al., Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland, BMJ, vol.327, issue.7422, 2003.
DOI : 10.1136/bmj.327.7422.1019

P. Gona, R. Van-dyke, P. Williams, W. Dankner, M. Chernoff et al., Incidence of Opportunistic and Other Infections in HIV-Infected Children in the HAART Era, JAMA, vol.296, issue.3, pp.292-300, 2006.
DOI : 10.1001/jama.296.3.292

A. Judd, K. Doerholt, P. Tookey, M. Sharland, A. Riordan et al., Morbidity, Mortality, and Response to Treatment by Children in the United Kingdom and Ireland with Perinatally Acquired HIV Infection during 1996-2006: Planning for Teenage and Adult Care, Clinical Infectious Diseases, vol.45, issue.7, pp.918-924, 2007.
DOI : 10.1086/521167

M. Mcconnell, R. Byers, T. Frederick, V. Peters, and K. Dominguez, Trends in Antiretroviral Therapy Use and Survival Rates for a Large Cohort of HIV-Infected Children and Adolescents in the United States, 1989-2001, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.488-494, 2005.
DOI : 10.1097/01.qai.0000134744.72079.cc

S. Nachman, J. Lindsey, J. Moye, K. Stanley, G. Johnson et al., Growth of Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy, The Pediatric Infectious Disease Journal, vol.24, issue.4, pp.352-357, 2005.
DOI : 10.1097/01.inf.0000157095.75081.43

K. Patel, M. Hernan, P. Williams, J. Seeger, K. Mcintosh et al., Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study, Clinical Infectious Diseases, vol.46, issue.4, pp.507-515, 2008.
DOI : 10.1086/526524

M. Newell, H. Coovadia, M. Cortina-borja, N. Rollins, and P. Gaillard, Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis, The Lancet, vol.364, issue.9441, pp.1236-1243, 2004.
DOI : 10.1016/S0140-6736(04)17140-7

J. Boerma, K. Stanecki, M. Newell, C. Luo, M. Beusenberg et al., Monitoring scale-up of antiretroviral therapy programmes, Bulletin of the World Health Organization, vol.84, issue.2
DOI : 10.2471/BLT.05.025189

L. Adams and P. Palumbo, The Time to Treat the Children Is Now, The Journal of Infectious Diseases, vol.195, issue.10, pp.1396-1398, 2007.
DOI : 10.1086/514824

C. Bolton-moore, M. Mubiana-mbewe, R. Cantrell, N. Chintu, E. Stringer et al., Clinical Outcomes and CD4 Cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia, JAMA, vol.298, issue.16, pp.1888-1899, 2007.
DOI : 10.1001/jama.298.16.1888

E. George, F. Noel, G. Bois, R. Cassagnol, L. Estavien et al., Antiretroviral Therapy for HIV???1???Infected Children in Haiti, The Journal of Infectious Diseases, vol.195, issue.10, pp.1411-1418, 2007.
DOI : 10.1086/514823

B. Janssens, R. B. Soeung, S. Akao, K. Te, V. Gupta et al., Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia, PEDIATRICS, vol.120, issue.5, pp.1134-1140, 2007.
DOI : 10.1542/peds.2006-3503

URL : https://hal.archives-ouvertes.fr/pasteur-00599045

M. Kabue, A. Kekitiinwa, A. Maganda, J. Risser, W. Chan et al., Growth in HIV-Infected Children Receiving Antiretroviral Therapy at a Pediatric Infectious Diseases Clinic in Uganda, AIDS Patient Care and STDs, vol.22, issue.3, pp.245-251, 2008.
DOI : 10.1089/apc.2007.0049

T. Puthanakit, L. Aurpibul, P. Oberdorfer, N. Akarathum, S. Kanjanavanit et al., SUSTAINED IMMUNOLOGIC AND VIROLOGIC EFFICACY AFTER FOUR YEARS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED CHILDREN IN THAILAND, The Pediatric Infectious Disease Journal, vol.26, issue.10, pp.953-956, 2007.
DOI : 10.1097/INF.0b013e318125720a

A. Reddi, S. Leeper, A. Grobler, R. Geddes, and K. France, Dorse GL Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa, BMC Pediatr, vol.7, 2007.

F. Rouet, P. Fassinou, A. Inwoley, M. Anaky, and A. Kouakoussui, Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens, AIDS, vol.20, issue.18, pp.2315-2319, 2006.
DOI : 10.1097/QAD.0b013e328010943b

D. Wamalwa, C. Farquhar, E. Obimbo, S. Selig, D. Mbori-ngacha et al., Early Response to Highly Active Antiretroviral Therapy in HIV-1???Infected Kenyan Children, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.PAP, pp.311-317, 2007.
DOI : 10.1097/QAI.0b013e318042d613

M. Newell, D. Patel, T. Goetghebuer, and C. Thorne, CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?, J Infect Dis, vol.193, pp.954-962, 2006.

K. Patel, M. Hern-n-Á, and P. Williams, Cell Evolution among Children and Adolescents Infected with HIV: 5 Years and Counting, Clinical Infectious Diseases, vol.46, issue.11, 2008.
DOI : 10.1086/587900

S. Resino, A. Alvaro-meca, M. De-jose, P. Martin-fontelos, M. Gutierrez et al., LOW IMMUNOLOGIC RESPONSE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN NAIVE VERTICALLY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-INFECTED CHILDREN WITH SEVERE IMMUNODEFICIENCY, The Pediatric Infectious Disease Journal, vol.25, issue.4, pp.365-368, 2006.
DOI : 10.1097/01.inf.0000207419.50016.5e

T. Puthanakit, L. Aurpibul, P. Oberdorfer, N. Akarathum, S. Kanjananit et al., Hospitalization and Mortality among HIV-Infected Children after Receiving Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.44, issue.4, pp.599-604, 2007.
DOI : 10.1086/510489

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924532

A. Violari, M. Cotton, and D. Gibb, Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study Abstract WESS103, The 4th IAS Conference on HIV Pathogenesis, Treatment, and Prevention Sydney, 2007.

J. Jackson, P. Musoke, T. Fleming, L. Guay, D. Bagenda et al., Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial, The Lancet, vol.362, issue.9387, pp.859-868, 2003.
DOI : 10.1016/S0140-6736(03)14341-3

M. Lallemant, G. Jourdain, L. Coeur, S. Mary, J. Ngo-giang-huong et al., Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand, New England Journal of Medicine, vol.351, issue.3, pp.217-228, 2004.
DOI : 10.1056/NEJMoa033500

E. Arrive, M. Newell, D. Ekouevi, M. Chaix, R. Thiebaut et al., Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis, International Journal of Epidemiology, vol.36, issue.5, pp.1009-1021, 2007.
DOI : 10.1093/ije/dym104

URL : https://hal.archives-ouvertes.fr/inserm-00187308

S. Lockman, R. Shapiro, L. Smeaton, C. Wester, I. Thior et al., Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine, New England Journal of Medicine, vol.356, issue.2, pp.135-147, 2007.
DOI : 10.1056/NEJMoa062876

A. Prendergast, W. Mphatswe, G. Tudor-williams, M. Rakgotho, V. Pillay et al., Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants, AIDS, vol.22, issue.11, 2008.
DOI : 10.1097/QAD.0b013e32830437df

K. Luzuriaga, M. Mcmanus, L. Mofenson, P. Britto, and B. Graham, A Trial of Three Antiretroviral Regimens in HIV-1???Infected Children, New England Journal of Medicine, vol.350, issue.24, pp.2471-2480, 2004.
DOI : 10.1056/NEJMoa032706

S. Welch and D. Gibb, When Should Children with HIV Infection Be Started on Antiretroviral Therapy, PLoS Medicine, vol.25, issue.3, 2008.
DOI : 0891-3668(2006)025[0987:IHAATI]2.0.CO;2

J. Orne-gliemann, R. Becquet, D. Ekouevi, V. Leroy, F. Perez et al., From research to policy and action in resource-limited settings, AIDS, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00192912